Camille P Vaughan Selected Research

Camille P Vaughan Research Topics

Disease

10	Urinary Incontinence 11/2023 - 06/2013
7	Overactive Urinary Bladder (Overactive Bladder) 01/2023 - 12/2011
7	Nocturia 01/2022 - 07/2009
4	Parkinson Disease (Parkinson's Disease) 01/2022 - 05/2015
3	Dementia (Dementias) 01/2023 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 11/2023 - 05/2017
2	Pneumonia (Pneumonitis) 03/2023 - 01/2023
2	Heart Failure 03/2023 - 01/2023
2	Chronic Obstructive Pulmonary Disease (COPD) 03/2023 - 01/2023
2	Syncope (Fainting) 03/2023 - 01/2023
2	Urinary Tract Infections (Urinary Tract Infection) 03/2023 - 01/2023
2	Myocardial Infarction 03/2023 - 01/2023
2	Dehydration (Water Stress) 03/2023 - 01/2023
2	Alzheimer Disease (Alzheimer's Disease) 03/2023 - 01/2023
2	Cognitive Dysfunction 01/2022 - 10/2021
2	Constipation 01/2019 - 05/2015
1	Obesity 11/2023
1	Hypertension (High Blood Pressure) 11/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2021
1	Alcoholism (Alcohol Abuse) 12/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 12/2020
1	Drug-Related Side Effects and Adverse Reactions 01/2019
1	Orthostatic Hypotension (Postural Hypotension) 01/2019
1	Urinary Retention 01/2019
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 05/2017
1	Parkinsonian Disorders (Parkinsonism) 12/2016
1	Bipolar Disorder (Manic Depressive Psychosis) 12/2016
1	Edema (Dropsy) 10/2016
1	Fecal Incontinence 02/2016
1	Xerostomia 05/2015
1	Diarrhea 05/2015
1	Pelvic Floor Disorders 01/2014
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 12/2011
1	Lower Urinary Tract Symptoms 12/2011
1	Vitamin D Deficiency 12/2011

Drug/Important Bio-Agent (IBA)

6	Vitamin D FDA LinkGeneric 01/2023 - 12/2011
2	25-hydroxyvitamin DIBA 11/2023 - 01/2023
2	Tamsulosin (Flomax)FDA LinkGeneric 01/2021 - 10/2016
2	Metformin (Glucophage)FDA LinkGeneric 12/2020 - 05/2017
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2019 - 07/2013
2	Adrenergic Antagonists (Antiadrenergic Agents)IBA 10/2016 - 07/2013
2	Muscarinic AntagonistsIBA 07/2013 - 12/2011
1	hydroxide ionIBA 11/2023
1	Atorvastatin (Lipitor)FDA Link 01/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 12/2020
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 12/2020
1	SodiumIBA 12/2020
1	Aligeron (AS 2)IBA 01/2020
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2019
1	LithiumIBA 12/2016
1	TabletsIBA 10/2016
1	A-factor (Streptomyces)IBA 02/2016
1	Solifenacin Succinate FDA Link 05/2015
1	Coffee FDA Link 06/2013
1	Caffeine (No Doz)FDA LinkGeneric 06/2013

Therapy/Procedure

12	Therapeutics 01/2023 - 07/2009
5	Drug Therapy (Chemotherapy) 01/2020 - 07/2009
3	Patient Readmission 03/2023 - 01/2023
3	Exercise Therapy (Therapy, Exercise) 01/2022 - 07/2013
2	Hysterectomy 05/2015 - 01/2014
1	Prostatectomy (Retropubic Prostatectomy) 01/2022
1	Self-Help Devices (Assistive Technology) 10/2021
1	Activities of Daily Living (ADL) 10/2021
1	Polypharmacy 12/2020
1	Contraindications 12/2020
1	Institutionalization (Institutionalized Persons) 01/2019
1	Aftercare (After-Treatment) 05/2015